Three- to Four-Year Follow-Up to an Open Trial of Nefazodone for Combat-Related Posttraumatic Stress Disorder

References

• Schlenger WE, Fairbank JA, Jordan BK, Caddell JM: Combat-related posttraumatic stress disorder: Prevalence, risk factors, and comorbidity. In: Saigh PA, Bremmer JD, eds. Post-traumatic Stress Disorder: A Comprehensive Text. Needham Heights, MA: Allyn and Bacon; 1999:69–91
   Google Scholar
• Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB: Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52:1048–1060
   PubMed Web of Science ®Google Scholar
• Yehuda R: Posttraumatic stress disorder. N Engl .1 Med 2002; 346(2):108–114
   Google Scholar
• Kessler RC: Posttraumatic stress disorder: The burden to the individual and to Society. J Clin Psychiatry 2000; 61(Suppl 5):4–12
   PubMed Web of Science ®Google Scholar
• Londborg P, Hegel MT, Goldstein S, Goldstein WM, Rausch J, Farfel GM: Sertraline treatment of posttraumatic stress disor-der: Results of 24 weeks of open-label continuation treatment. J Clin Psychiatry 2001; 62(5):325–331
   PubMed Web of Science ®Google Scholar
• Davidson JRT: Pharmacotherapy of posttraumatic stress dis-order: Treatment options, long-term follow-up and predictors of outcome. J Clin Psychiatry 2000; 61(Suppl 5):52–56
   Google Scholar
• Davidson JRT, Pearlstein T, Londborg P, Brady K, Rothbaum BO, Bell J, Maddock R, Hegel MT, Farfel GM: Efficacy of sertraline in preventing relapse of posttraumatic stress dis-order: Results of a twenty-eight week double-blind placebo-controlled study. Am J Psychiatry 2001; 158(12):1974–1981
   PubMed Web of Science ®Google Scholar
• Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JRT: Open trial of nefazodone for combat-related posttraumatic stress disorder. I Clin Psychiatry 1998; 59(9):460–464
   Google Scholar
• Hidalgo RB, Hertzberg MA, Mellman T, Petty F, Tucker P, Weisler R, Zisook S, Chen S, Churchill E, Davidson JRT:.Ne-fazodone in post-traumatic stress disorder: Results from six open-label trials. Int Clin Psychopharmacol 1999; 14:61–68
   Google Scholar
• Voris IC, Voris CT, Kaltsounis J: Use of nefazodone in the treatment of posttraumatic stress disorder. Veterans Health System J 2001; 6:61–65
   Google Scholar
• Zisook S, Chentsova-Dutton BA, Smith-Vaniz A, Kline NA, Ellenor GL, Kodsi AB, Gillin IC: Nefazodone in patients with treatment-refractory posttraumatic stress disorder. J Clin Psy-chiatry 2000; 61:203–208
   Google Scholar
• Davis LL, Nugent AL, Murray I, Kramer GL, Petty F: Ne-fazodone treatment for chronic posttraumatic stress disorder: An open trial. J Clin Psychopharmacol 2000; 20:159–164
   PubMedGoogle Scholar
• Mellman T, David D, Barza L: Nefazodone treatment and dream reports in chronic PTSD. Depress Anxiety 1999; 9:146–148
   Google Scholar
• Garfield DAS, Fichtner CG, Leveroni C, Mahableshwarkar A: Open trial of nefazodone for combat veterans with posttrau-matic stress disorder. J Trauma Stress 2001; 14:453–460
   Google Scholar
• Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M: Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993; 50:294–305
   Web of Science ®Google Scholar
• Connor KM, Davidson JRT: The role of serotonin in posttrau-matic stress disorder: Neurobiology and pharmacotherapy. CNS Spectrums 1999; 3:42–51
   Google Scholar
• Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum BO, Sikes CR, Farfel GM: Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. JAMA 2000; 283:1837–1844
   PubMed Web of Science ®Google Scholar
• Davidson JRT, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM: Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001; 58:485–492
   PubMed Web of Science ®Google Scholar
• Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD: Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001; 62:860–868
   PubMed Web of Science ®Google Scholar
• Marshall RD, Beebe KL, Oldham M, Zaninelli R: Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. Am J Psychiatry 2001; 158:1982–1988
   PubMed Web of Science ®Google Scholar
• Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JRT: Fluoxetine in posttraumatic stress disorder: Randomized double blind study. Br J Psychiatry 1999; 175:17–22
   PubMed Web of Science ®Google Scholar
• Gitlin MJ: Psychotropic medications and their effects on sexualfunction: Diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994; 55:406–413
   PubMed Web of Science ®Google Scholar
• Marek GJ, McDougle CJ, Price LH, Seiden LS: A compari-son of trazodone and fluoxetine: Implications for a serotoner-gic mechanism of antidepressant action. Psychopharmacology 1992; 109:2–11
   PubMed Web of Science ®Google Scholar
• Beasley CM, Dornseif BE, Pultz JA, Bosomworth JC, Saylor ME: Fluoxetine versus trazodone: Efficacy and activating-sedating effects. J Clin Psychiatry 1991; 52:294–299
   PubMed Web of Science ®Google Scholar
• Mellman T, Kulick-Bell R, Ashlock LE, Nolan B: Sleep events among veterans with combat-related posttraumatic stress dis-order. Am J Psychiatry 1995; 152:110–115
   PubMed Web of Science ®Google Scholar
• Eison AS, Eison MS, Torrente JR, Wright RN, Yocca FD: Ne-fazodone: Preclinical pharmacology of a new antidepressant. Psychopharmacol Bull 1990; 26:311–315
   PubMed Web of Science ®Google Scholar
• Taylor DP, Carter RB, Eison AS, Mullins UL, Smith HL, Torrente JR, Wright RN, Yocca FD: Pharmacology and neu-rochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry 1995; 56 (Suppl 6):3–11
   PubMedGoogle Scholar
• Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP: The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 1994; 10:123–127
   PubMed Web of Science ®Google Scholar
• Sharpley AL, Walsh AES, Cowen PJ: Nefazodone-a novel antidepressant-may increase REM sleep. Biol Psychiatry 1992; 31:1070–1073
   PubMed Web of Science ®Google Scholar
• Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS: Nefazodone versus sertraline in outpatients with major de-pression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57:53–62
   PubMed Web of Science ®Google Scholar
• Gillin JC, Smith-Vaniz A, Schnierow B, Rapaport MH, Kelsoe J, Raimo E, Marler MR, Goyette LM, Stein MB, Zisook S: An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. J Clin Psychiatry 2001; 62:789–796
   Google Scholar
• Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM: The development of a clinician-administered PTSD scale. J Trauma Stress 1995; 8:75–80
   PubMed Web of Science ®Google Scholar
• Davidson JRT, Book SW, Colket JT, Thpler LA, Roth S, David D, Hertzberg MA, Mellman T, Beckham JC, Smith RD, Davidson RM, Katz R, Feldman ME: Assessment of a new self-rating scale for posttraumatic stress disorder: The Davidson Trauma Scale. Psychol Med 1997; 27:153–160
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: A new instrument of psychiatric practice and research. Psychiatry Res 1989; 28:193–213
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA: The Revised Beck Depression Inventory. San Antonio: Psychological Corporation; 1987
   Google Scholar
• Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62
   PubMed Web of Science ®Google Scholar
• Guy W: ECDEU Assessment Manual for psychopharmacol-ogy. Rockville, MD: National Institute of Mental Health; 1976. U.S. Department of Health, Education, and Welfare publication (ADM)
   Google Scholar
• Keane TM, Fairbank JA, Caddell JM, Zimering RT, Taylor KL, Mora C: Clinical evaluation of a measure to assess combat exposure. Psychol Assess J Consult Clin Psychol 1989; 1:53–55
   Google Scholar
• Keane TM, Caddell JM, Taylor KL: Mississippi scale for combat-related posttraumatic stress disorder: Three studies in reliability and validity. J Consult Clin Psychol 1988; 56:75–80
   Google Scholar
• Hertzberg MA, Feldman ME, Beckham JC, Davidson JRT: Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 1996; 16:294–298
   PubMed Web of Science ®Google Scholar
• Nagy LM, Morgan CA, Southwick SM, Steven M, Charney DS: Open prospective trial of fluoxetine for posttraumatic stress disorder. J Psychopharmacol 1993; 13:107–113
   Google Scholar
• Shay J: Fluoxetine reduces explosiveness and elevates mood of Vietnam combat veterans with PTSD. J Trauma Stress 1992; 5:97–101
   Web of Science ®Google Scholar
• Marmar CR, Schoenfeld F, Weiss DS, Metzler T, Zatzick D, Wu RM, Smiba S, Tecott L, Neylan T: Open Trial of fluvox-amine treatment for combat-related posttraumatic stress dis-order. J Clin Psychiatry 1996; 57:66–72
   PubMed Web of Science ®Google Scholar
• Nierenberg AA: Long-term management of chronic depres-sion. J Clin Psychiatry 2001; 62:17–21
   Google Scholar
• Davidson JRT: The long-term treatment of panic disorder. J Clin Psychiatry 1998; 59:17–21
   Google Scholar
• Davidson JRT: Pharmacotherapy of social anxiety disorder. J Clin Psychiatry 1998; 59:47–51
   Google Scholar
• Schatzberg AF, Prather MR: Use of nefazodone in major depression. J Clin Psychiatry 2002; 63:19–24
   Google Scholar
• Dunner DL, Laird LK: Comparative safety and tolerability of nefazodone. J Clin Psychiatry 2002; 63:33–36
   Google Scholar
• Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, McFarlane AC, Shalev A: Consensus statement on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry 2000; 61 (Suppl 5)
   Google Scholar
• Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JRT: Lack of efficacy for fluoxetine in PTSD: A placebo controlled trial in combat veterans. Ann Clin Psychi-atry 2000; 12:101–105
   PubMedGoogle Scholar
• Foa EB, Davidson JRT, Frances A, eds.: Treatment of post-traumatic stress disorder [The Expert Consensus Guideline Series]. J Clin Psychiatry 1999; 60 (Suppl 16)
   Google Scholar